Pronóstico del mercado europeo de kits de pruebas rápidas hasta 2030 – Análisis regional – por tipo (pruebas rápidas de antígenos, pruebas rápidas de anticuerpos y otros), producto (kit de pruebas rápidas de venta libre y kit de pruebas rápidas profesional), tecnología (ensayo de flujo lateral, Fase sólida, aglutinación, ensayo de inmunospot y basado en componentes celulares), aplicación (pruebas de glucosa en sangre, pruebas de enfermedades infecciosas, embarazo y fertilidad, pruebas cardiometabólicas y otras) y usuario final (hospitales y clínicas, atención domiciliaria, centros de diagnóstico, y otros)
Las iniciativas estratégicas de los fabricantes impulsan el mercado europeo de kits de pruebas rápidas
Los fabricantes del mercado de kits de pruebas rápidas hacen hincapié en la adopción de estrategias como innovaciones, lanzamientos y aprobaciones de productos para mantener una ventaja competitiva en el mercado. Estas iniciativas estratégicas de las empresas del mercado de kits de pruebas rápidas benefician al mercado en general.
En 2022, el fabricante de diagnósticos con sede en Singapur INEX Innovate, pionero en el sector de la salud fetal y de la mujer en Asia, recibió la marca CE para OvaCis Rapid Test, su solución insignia para el cáncer de ovario. A finales de 2022, se espera que OvaCis, la primera prueba de su tipo en el lugar de atención (POCT, por sus siglas en inglés) que distingue los quistes ováricos benignos de los malignos en un quirófano, haga su debut en la UE y el Sudeste Asiático. mercados.
En enero de 2022, OraSure Technologies, Inc., líder mundial en pruebas de diagnóstico domiciliarias y en el lugar de atención, así como en tecnologías de recolección de muestras, lanzó la autoprueba de VIH OraQuick, un hisopo oral basado en -Test casero de VIH-1 y VIH-2, para el mercado europeo. La prueba está disponible en seis países europeos: Reino Unido, Francia, Alemania, Italia, España y Portugal.
En 2021, tras la emisión del certificado CE, FUJIFILM Europe GmbH recibió autorización para aplicar la marca CE e introducir un kit de prueba de antígenos para el diagnóstico de la infección por SARS-CoV-2. La técnica que utiliza Fujifilm se llama inmunocromatografía de amplificación de plata patentada y se basa en la misma tecnología que se utiliza para amplificar las fotografías que se van a revelar.
En diciembre de 2020, la Administración de Alimentos y Medicamentos de EE. UU. (FDA) emitió una Autorización de uso de emergencia (EUA) para una prueba rápida guiada virtualmente BinaxNOW COVID-19 Ag Card (de Abbott), indicada para personas en casa. Uso para la detección de COVID-19. BinaxNOW es una prueba rápida ampliamente distribuida y una de las más asequibles, que proporciona resultados en minutos.
En julio de 2020, la FDA otorgó una autorización de uso de emergencia (EUA) para una prueba de diagnóstico rápida de SARS-CoV-2 en el lugar de atención para su uso con su sistema BD Veritor Plus, ampliamente disponible. El nuevo ensayo genera resultados en 15 minutos en un instrumento altamente portátil y fácil de usar. La prueba estaba destinada a mejorar el acceso a los diagnósticos de COVID-19 proporcionando resultados en tiempo real y ayudando a tomar decisiones rápidas mientras el paciente todavía se encuentra en el centro de pruebas.
Descripción general del mercado europeo de kits de pruebas rápidas
La prevalencia de la diabetes en Alemania ha aumentado significativamente. Según la Federación Internacional de Diabetes, en 2021 ~62 millones de personas padecían diabetes. Además, según el informe del Centro Europeo para la Prevención y el Control de Enfermedades, en 2019 se registraron 8.641 casos de malaria en la Unión Europea (UE), de los cuales 8.638 (>99%) fueron diagnósticos confirmados. En septiembre de 2022, Alemania firmó un acuerdo por valor de 1.340 millones de dólares con el Programa Conjunto de las Naciones Unidas sobre el VIH/SIDA (ONUSIDA) con el objetivo de luchar contra el SIDA, la tuberculosis y la malaria; Con esto, el país aumentó su contribución en un 30% en comparación con 2019. Además, según el informe de endmalaria.org 2020, las fuentes internacionales proporcionaron el 69% del financiamiento total destinado al control y eliminación de la malaria. La financiación total para el control y la eliminación de la malaria representó 3.300 millones de dólares, incluidos 200 millones de dólares aportados por Alemania. Por lo tanto, es probable que el mercado de kits de pruebas rápidas crezca en Alemania en los próximos años con la creciente prevalencia de enfermedades infecciosas como la diabetes, el SIDA, la tuberculosis y la malaria.
Ingresos del mercado europeo de kits de prueba rápida y pronóstico hasta 2030 (millones de dólares estadounidenses)
Segmentación del mercado europeo de kits de prueba rápida
El mercado europeo de kits de prueba rápida está segmentado según el tipo , producto, tecnología, aplicación, usuario final y país. Según el tipo, el mercado europeo de kits de pruebas rápidas se segmenta en pruebas rápidas de antígenos, pruebas rápidas de anticuerpos y otras. El segmento de pruebas rápidas de antígenos tuvo la mayor participación de mercado en 2022.
En términos de producto, el mercado europeo de kits de pruebas rápidas se divide en kits de pruebas rápidas de venta libre y kits de pruebas rápidas profesionales. El segmento de kits de pruebas rápidas de venta libre tuvo una mayor participación de mercado en 2022.
Por tecnología, el mercado europeo de kits de pruebas rápidas se segmenta en ensayo de flujo lateral, fase sólida, aglutinación, ensayo de inmunomanchas y ensayo celular basado en componentes. El segmento de ensayo de flujo lateral tuvo la mayor participación de mercado en 2022.
Según la aplicación, el mercado europeo de kits de prueba rápida se clasifica en pruebas de glucosa en sangre, pruebas de enfermedades infecciosas, embarazo y fertilidad, pruebas cardiometabólicas y otras. El segmento de pruebas de glucosa en sangre tuvo la mayor participación de mercado en 2022.
En términos de usuario final, el mercado europeo de kits de pruebas rápidas está segmentado en hospitales y clínicas, atención domiciliaria, centros de diagnóstico y otros. El segmento de hospitales y clínicas tuvo la mayor participación de mercado en 2022.
Según el país, el mercado europeo de kits de pruebas rápidas está segmentado en el Reino Unido, Alemania, Francia, Italia, España y el resto de Europa. Alemania dominó la cuota de mercado europea de kits de pruebas rápidas en 2022.
F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Sysmex Partec GmbH, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA y Beckman Coulter Inc son algunos de los principales actores que operan en el mercado europeo de kits de pruebas rápidas.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Rapid Test Kits Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Genetic and Infectious Diseases
4.1.2 Strategic Initiatives by Manufacturers
4.2 Market Restraints
4.2.1 Uncertainties Related to Accuracy of Results
4.3 Market Opportunities
4.3.1 Increasing Preference for PCR Techniques
4.4 Future Trends
4.4.1 Innovations in Rapid Antigen Tests
4.5 Impact Analysis
5. Rapid Test Kits Market - Europe Market Analysis
5.1 Overview
5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
6. Europe Rapid Test Kits Market Analysis - by Type
6.1 Overview
6.2 Rapid Antigen Testing
6.2.1 Overview
6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Rapid Antibody Testing
6.3.1 Overview
6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Rapid Test Kits Market Analysis - by Product
7.1 Overview
7.2 Over-the-Counter Rapid Testing Kit
7.2.1 Overview
7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Professional Rapid Testing Kit
7.3.1 Overview
7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Rapid Test Kits Market Analysis - by Technology
8.1 Overview
8.2 Lateral Flow Assay
8.2.1 Overview
8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Solid Phase
8.3.1 Overview
8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Agglutination
8.4.1 Overview
8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Immunospot Assay
8.5.1 Overview
8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Cellular-Component Based
8.6.1 Overview
8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Rapid Test Kits Market Analysis - by Application
9.1 Overview
9.2 Blood Glucose Testing
9.2.1 Overview
9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Infectious Disease Testing
9.3.1 Overview
9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
9.4.1 Overview
9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Pregnancy and Fertility
9.5.1 Overview
9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Rapid Test Kits Market Analysis - by End User
10.1 Overview
10.2 Hospital and Clinics
10.2.1 Overview
10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Home-Care
10.4.1 Overview
10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11. Europe Rapid Test Kits Market - Country Analysis
11.1 Europe
11.1.1 Europe: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
11.1.1.1 Germany
11.1.1.1.1 Overview
11.1.1.2 Germany: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.1 Germany: Rapid Test Kits Market Breakdown, by Type
11.1.1.2.2 Germany: Rapid Test Kits Market Breakdown, by Product
11.1.1.2.3 Germany: Rapid Test Kits Market Breakdown, by Technology
11.1.1.2.4 Germany: Rapid Test Kits Market Breakdown, by Application
11.1.1.2.4.1 Germany: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.2.5 Germany: Rapid Test Kits Market Breakdown, by End User
11.1.1.3 United Kingdom
11.1.1.3.1 Overview
11.1.1.4 United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Type
11.1.1.4.2 United Kingdom: Rapid Test Kits Market Breakdown, by Product
11.1.1.4.3 United Kingdom: Rapid Test Kits Market Breakdown, by Technology
11.1.1.4.4 United Kingdom: Rapid Test Kits Market Breakdown, by Application
11.1.1.4.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.4.5 United Kingdom: Rapid Test Kits Market Breakdown, by End User
11.1.1.5 France
11.1.1.5.1 Overview
11.1.1.6 France: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.6.1 France: Rapid Test Kits Market Breakdown, by Type
11.1.1.6.2 France: Rapid Test Kits Market Breakdown, by Product
11.1.1.6.3 France: Rapid Test Kits Market Breakdown, by Technology
11.1.1.6.4 France: Rapid Test Kits Market Breakdown, by Application
11.1.1.6.4.1 France: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.6.5 France: Rapid Test Kits Market Breakdown, by End User
11.1.1.7 Italy
11.1.1.7.1 Overview
11.1.1.8 Italy: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.8.1 Italy: Rapid Test Kits Market Breakdown, by Type
11.1.1.8.2 Italy: Rapid Test Kits Market Breakdown, by Product
11.1.1.8.3 Italy: Rapid Test Kits Market Breakdown, by Technology
11.1.1.8.4 Italy: Rapid Test Kits Market Breakdown, by Application
11.1.1.8.4.1 Italy: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.8.5 Italy: Rapid Test Kits Market Breakdown, by End User
11.1.1.9 Spain
11.1.1.9.1 Overview
11.1.1.10 Spain: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.10.1 Spain: Rapid Test Kits Market Breakdown, by Type
11.1.1.10.2 Spain: Rapid Test Kits Market Breakdown, by Product
11.1.1.10.3 Spain: Rapid Test Kits Market Breakdown, by Technology
11.1.1.10.4 Spain: Rapid Test Kits Market Breakdown, by Application
11.1.1.10.4.1 Spain: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.10.5 Spain: Rapid Test Kits Market Breakdown, by End User
11.1.1.11 Rest of Europe
11.1.1.11.1 Overview
11.1.1.12 Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.12.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Type
11.1.1.12.2 Rest of Europe: Rapid Test Kits Market Breakdown, by Product
11.1.1.12.3 Rest of Europe: Rapid Test Kits Market Breakdown, by Technology
11.1.1.12.4 Rest of Europe: Rapid Test Kits Market Breakdown, by Application
11.1.1.12.4.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.12.5 Rest of Europe: Rapid Test Kits Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Rapid Test Kit Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Becton Dickinson and Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ARKRAY Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sysmex Partec GmbH
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Fujirebio Europe NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 bioMerieux SA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Cepheid
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Meril Life Sciences Pvt Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 QIAGEN NV
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 OraSure Technologies Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Guangzhou Wondfo Biotech Co Ltd
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Denka Co Ltd
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Abbott Laboratories
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 Trinity Biotech Plc
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Bio-Rad Laboratories Inc
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 Hologic Inc
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 DiaSorin SpA
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 Premier Medical Corp Pvt Ltd
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
13.19 Beckman Coulter Inc
13.19.1 Key Facts
13.19.2 Business Description
13.19.3 Products and Services
13.19.4 Financial Overview
13.19.5 SWOT Analysis
13.19.6 Key Developments
14. Appendix
14.1 About The Insight Partners
List of Tables
Table 1. Rapid Test Kits Market Segmentation
Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 4. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 5. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 6. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 7. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 8. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 10. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 11. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 12. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 13. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 14. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 16. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 17. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 18. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 20. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 22. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 23. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 24. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 25. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 26. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 27. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 28. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 30. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 31. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 32. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 33. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 34. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 35. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 36. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 37. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 38. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 39. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
Table 40. Recent Organic Growth Strategies in the Rapid Test Kit Market
List of Figures
Figure 1. Rapid Test Kits Market Segmentation, By Country
Figure 2. Rapid Test Kits Market: Key Industry Dynamics
Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)
Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)
Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)
Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)
Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)
Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Europe: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
Figure 30. Europe: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 31. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 34. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Growth Strategies in the Rapid Test Kit Market
1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. Sysmex Partec GmbH
4. ARKRAY Inc
5. Fujirebio Europe NV
6. bioMerieux SA
7. Cepheid
8. Meril Life Sciences Pvt Ltd
9. QIAGEN NV
10. OraSure Technologies Inc
11. Guangzhou Wondfo Biotech Co Ltd
12. Denka Co Ltd
13. Abbott Laboratories
14. Trinity Biotech Plc
15. Bio-Rad Laboratories Inc
16. Hologic Inc
17. Premier Medical Corp Pvt Ltd
18. DiaSorin SpA
19. Beckman Coulter Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe rapid test kit market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe rapid test kit market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe rapid test kit market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.